Positron emission mammography for breast cancer diagnosis
Part of Cancer, Skin clinical trials.
This trial tests whether a special imaging test called positron emission mammography (PEM) can accurately detect breast cancer. It might help improve diagnosis and planning for people suspected of having the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You may have a suspicious breast finding or symptoms that suggest breast cancer
- You are not pregnant
- Your blood sugar level is 200 mg/dl or lower
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new PET scan machine for the breast (positron emission mammography) along with a blood test called a liquid biopsy for women who need a biopsy after a high-risk breast screening. It may help find cancer more accurately and less invasively.
This early study tests a special PET scan (a type of imaging) to look at newly diagnosed ER-positive breast cancer. The goal is to see how well the scan can detect and measure cancer, which may help guide care.
This study tests whether getting a contrast-enhanced mammogram (CEM) every two years is effective for detecting breast cancer in women who have had breast cancer before. If you qualify, you will receive CEM instead of a standard mammogram to see if it helps find cancer earlier.
This trial uses a special PET/CT scan to find breast cancer cells that have a certain marker (CD73). It may help doctors see the cancer more clearly before you start other treatments.
This study tests whether a new type of PET/MRI scan can help doctors see how well breast cancer treatment is working. It is a platform study, meaning it can evaluate different treatments, but the focus is on using this advanced imaging to monitor response.
This study tests whether a special type of mammogram, called contrast-enhanced mammography (CEM), can better spot additional breast abnormalities that were seen on your MRI. It might help doctors decide on the best next steps without needing more invasive tests.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.